Venus Remedies secures firstiInternational market authorization for Sugammadex from the Philippines
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
The basket acquired, comprises of 13 ANDAs, which are approved by the USFDA and 1 ANDA, which is pending approval from the USFDA
Glenmark acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials from Aspen Pharma USA
In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
The PIPE offering consists of 36,190,476 units
Yearbook members are selected basis their S&P Global 2024 Corporate Sustainability Assessment score
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
Subscribe To Our Newsletter & Stay Updated